Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice-Reference-Cited by-同舟云学术

Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice

Published:2019-10 Issue: Volume:118 Page:109131
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Wang,Xu Ji-Hao,Yu Tao,Chen Qi-Kui

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference39 articles.

1. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations;Tang;J. Ethnopharmacol.,2009

2. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins;Kong;Nat. Med.,2004

3. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine;Zhang;J. Clin. Endocrinol. Metab.,2008

4. Berberine: a potential phytochemical with multispectrum therapeutic activities;Vuddanda;Expert Opin. Investig. Drugs,2010

5. Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms;Zhang;China J. Chin. Mater. Med. Zhongguo Zhong Yao Za Zhi,2015

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysaccharide NAP-3 Synergistically Enhances the Efficiency of Metformin in Type 2 Diabetes via Bile Acid/GLP-1 Axis through Gut Microbiota Remodeling;Journal of Agricultural and Food Chemistry;2024-09-11

2. Inhibition on neutrophil extracellular traps by oligomeric procyanidins alleviate chemotherapy-induced chronic kidney injury via gut-kidney axis;2024-09-07

3. Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia;Neurochemical Research;2024-09-06

4. Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance;Proceedings of the National Academy of Sciences;2024-09-03

5. Improving Type 2 Diabetes Care with Extended-Release Metformin: Real-Life Insights from a Physician Educational Program;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-09